Effect of Non-Compressive Semiconductor Embedded Therapeutic Gloves on Osteoarthritis of the Hand
Effect of Non-Compressive Semiconductor Embedded Therapeutic Gloves on Osteoarthritis of the Hand: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial
This clinical trial will investigate whether non-compressive therapeutic gloves improve hand function and reduce pain in people with hand osteoarthritis. The gloves contain semiconductor elements embedded in their fabric. Researchers will compare these gloves with visually identical placebo gloves that do not contain semiconductor elements.
The main question is whether the active gloves improve hand function after 12 weeks compared with placebo gloves. Researchers will also assess pain, grip strength, symptoms and changes seen on magnetic resonance imaging (MRI) over nine months.
The study will involve at least 154 participants aged 39 years or older with diagnosed hand osteoarthritis who do not require immediate hand surgery. It will take place at MSK House in Sleaford, United Kingdom.
After providing written informed consent, participants will be assigned by chance to one of two groups. Each participant will have an equal chance of receiving active or placebo gloves. Neither participants nor the clinical team will know which gloves have been assigned.
Participants will:
- Wear the assigned glove or gloves on their affected hand or hands for at least 20 hours each day, including overnight, during the first 12 weeks.
- Continue wearing the gloves for at least 12 hours each day, including overnight, for the remainder of the nine-month study.
- Complete questionnaires about hand pain and function before treatment and at three, six and nine months.
- Attend the study site at the beginning and at nine months for assessments, including grip strength testing and MRI scans of the hand and wrist.
- Record their hand pain, glove use and pain medication use in a weekly diary.
Participants may also complete a short video-based movement assessment at the first and last study visits.
The main measure of hand function will be the Australian Canadian Osteoarthritis Hand Index (AUSCAN), a questionnaire about hand symptoms and difficulty with everyday activities. Other assessments will measure pain, hand function, grip strength and changes in the hand joints.
The research team will record unwanted effects during the study. Participants who experience discomfort, irritation or a skin reaction will be advised to remove the gloves and contact the study team.
The findings will help determine whether these therapeutic gloves have a role in managing hand osteoarthritis.
調査の概要
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Paul Lee
- 電話番号:+44 330 001 0048
- メール:research@mskdoctors.com
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Diagnosed erosive hand osteoarthritis, non-erosive hand osteoarthritis or first carpometacarpal joint osteoarthritis.
- Mild, moderate or severe hand osteoarthritis on MRI assessment, without an indication for immediate surgery.
- Hand pain attributable to diagnosed hand osteoarthritis within the previous six months.
- Aged 39 years or older.
- Willing and able to comply with the follow-up schedule and study requirements.
- Willing and able to provide written informed consent.
Exclusion Criteria:
- Known history of neurological conditions, including multiple sclerosis or Parkinson's disease.
- Surgical treatment of the hands within the previous five years or injection treatment of the hands within the previous six months.
- An indication for immediate surgery to treat hand osteoarthritis.
- Secondary causes of arthritis, including gout, rheumatoid arthritis or psoriatic arthritis.
- Use of topical creams or gels for arthritic pain within the previous week, including non-steroidal anti-inflammatory drugs, capsaicin, lidocaine or counterirritants.
- History of carpal tunnel syndrome, cubital tunnel syndrome or radial tunnel syndrome.
- History of peripheral neuropathy.
- Chronic pain conditions unrelated to the hand condition.
- Known autoimmune disease other than arthritis.
- Tobacco use within the previous 90 days.
- Aged under 39 years.
- Active local or systemic infection.
- Unwilling or unable to provide written informed consent.
- Any other condition or circumstance that, in the investigator's opinion, would prevent completion of the study or confound the study results.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Icrediwear Group
Participants receive active semiconductor-embedded gloves to wear on their affected hand or hands for nine months. Gloves are worn for a minimum of 20 hours per day, including overnight, during the first 12 weeks, followed by at least 12 hours per day, including overnight, until the nine-month assessment. |
Non-compressive therapeutic gloves with semiconductor elements incorporated into the fabric. The gloves cover the hand and fingers, with open fingertips. The research team selects the appropriate size, fits the gloves and provides instructions for use. |
|
プラセボコンパレーター:Placebo Group
Participants receive identical gloves without semiconductor elements to wear on their affected hand or hands for nine months. Gloves are worn for a minimum of 20 hours per day, including overnight, during the first 12 weeks, followed by at least 12 hours per day, including overnight, until the nine-month assessment. |
Visually identical non-compressive gloves without semiconductor elements. The gloves cover the hand and fingers, with open fingertips. The research team selects the appropriate size, fits the gloves and provides instructions for use. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
時間枠 |
|---|---|
|
Change in Hand Function Assessed Using the Australian Canadian Osteoarthritis Hand Index (AUSCAN)
時間枠:Baseline and 12 weeks
|
Baseline and 12 weeks
|
二次結果の測定
結果測定 |
時間枠 |
|---|---|
|
Change in Hand Pain Assessed Using a Visual Analogue Scale
時間枠:Baseline and months 3, 6 and 9.
|
Baseline and months 3, 6 and 9.
|
|
Change in Functional Index for Hand Osteoarthritis (FIHOA) Score
時間枠:Baseline and months 3, 6 and 9.
|
Baseline and months 3, 6 and 9.
|
|
Change in Grip Strength
時間枠:Baseline and month 9.
|
Baseline and month 9.
|
協力者と研究者
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
- 2024-24
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。